Compounds > repaglinide
Page last updated: 2024-08-24

repaglinide and c-peptide

repaglinide has been researched along with c-peptide in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's13 (81.25)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyages, S; Carter, J; Colagiuri, S; Donnelly, T; Hopkins, H; Kidson, W; Moffitt, P; Moses, R; Slobodniuk, R1
Huang, WC; Lebovitz, H; Marbury, T; Strange, P1
Dejgaard, A; Hollingdal, M; Juhl, CB; Pincus, S; Pørksen, N; Schmitz, O; Sturis, J; Veldhuis, JD1
Bayer, T; Ismail, I; Luzio, SD; Owens, DR1
Goldberg, RB; Strange, P1
Dejgaard, A; Kilhovd, B; Lager, I; Madsbad, S; Mustajoki, P1
Backman, JT; Neuvonen, M; Neuvonen, PJ; Niemi, M1
Fragoulopoulos, E; Karabina, SP; Katsilambros, N; Kitsou, E; Kolia, M; Kyriaki, D; Perea, D; Sala, C; Tambaki, AP; Tentolouris, N; Tselepis, AD1
Carr, RD; Degn, KB; Gall, MA; Rizza, RA; Schmitz, O; Thomsen, MK; Veldhuis, JD; Østergård, T1
Barbieri, M; Barone, M; Grella, R; Paolisso, G; Passariello, N; Rizzo, MR1
Leyck Dieken, MG; Pfeiffer, AF; Rochlitz, H; Rudovich, NN1
Hofmann, U; Paulwitz, O; Rosak, C1
Cozma, LS; Dunseath, GJ; Luzio, SD; Owens, DR; Underwood, PM1
Frandsen, M; Lund, SS; Parving, HH; Pedersen, O; Schalkwijk, CG; Smidt, UM; Stehouwer, CD; Tarnow, L; Vaag, A1
Arnqvist, HJ; Chisalita, SI; Eson Jennersjö, P; Lindström, T; Olsson, AG; Paulsson, JF; Westermark, GT1
Möhlig, M; Otto, B; Pfeiffer, AF; Pivovarova, O; Rudovich, N; Spranger, J; Weickert, MO1

Trials

15 trial(s) available for repaglinide and c-peptide

ArticleYear
Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
    Diabetes care, 1999, Volume: 22, Issue:1

    Topics: Australia; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidines; Triglycerides

1999
Repaglinide versus glyburide: a one-year comparison trial.
    Diabetes research and clinical practice, 1999, Volume: 43, Issue:3

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fibrinogen; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines; Prospective Studies; Triglycerides; United States; United States Food and Drug Administration

1999
Repaglinide acutely amplifies pulsatile insulin secretion by augmentation of burst mass with no effect on burst frequency.
    Diabetes care, 2000, Volume: 23, Issue:5

    Topics: Adult; Blood Glucose; C-Peptide; Carbamates; Cross-Over Studies; Double-Blind Method; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Kinetics; Male; Piperidines; Placebos

2000
Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:4

    Topics: Administration, Oral; Area Under Curve; Blood Glucose; C-Peptide; Carbamates; Cohort Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Eating; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Piperidines

2000
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
    Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:5

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Fasting; Female; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Piperidines

2001
Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide.
    Diabetologia, 2003, Volume: 46, Issue:3

    Topics: Adult; Antifungal Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blood Glucose; C-Peptide; Carbamates; Cross-Over Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Gemfibrozil; Half-Life; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Itraconazole; Male; Piperidines

2003
Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:6

    Topics: Analysis of Variance; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Insulin; Kinetics; Piperidines; Postprandial Period; Triglycerides

2003
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:1

    Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Glyburide; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Piperidines; Placebos; Potassium Channel Blockers; Somatostatin

2004
Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study.
    Diabetes & metabolism, 2004, Volume: 30, Issue:1

    Topics: Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Diabetes Mellitus, Type 2; Female; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Middle Aged; Piperidines; Postprandial Period; Sulfonylurea Compounds; Time Factors; Triglycerides

2004
Enhancement of early- and late-phase insulin secretion and insulin sensitivity by the combination of repaglinide and metformin in type 2 diabetes mellitus.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2004, Volume: 112, Issue:7

    Topics: Adult; Aged; C-Peptide; Carbamates; Cohort Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Metformin; Middle Aged; Piperidines; Placebos; Time Factors

2004
Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Diabetes, nutrition & metabolism, 2004, Volume: 17, Issue:3

    Topics: Acarbose; Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Food; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Middle Aged; Piperidines; Proinsulin

2004
Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.
    Diabetes care, 2005, Volume: 28, Issue:5

    Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Eating; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Piperidines; Postprandial Period

2005
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
    Diabetes, obesity & metabolism, 2007, Volume: 9, Issue:3

    Topics: Adiponectin; Biomarkers; Blood Glucose; Body Weight; C-Peptide; C-Reactive Protein; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Patient Compliance; Piperidines; Prospective Studies; Waist-Hip Ratio

2007
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Acta diabetologica, 2009, Volume: 46, Issue:1

    Topics: Aged; Apolipoproteins; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Lipids; Lipoproteins; Male; Middle Aged; Piperidines; Proinsulin

2009
Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus.
    Diabetes technology & therapeutics, 2010, Volume: 12, Issue:1

    Topics: Adult; Aged; Benzamides; Blood Glucose; Body Mass Index; C-Peptide; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 2; Eating; Feeding Behavior; Ghrelin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Piperidines; Reference Values; Single-Blind Method

2010

Other Studies

1 other study(ies) available for repaglinide and c-peptide

ArticleYear
Repaglinide dose response? A clinician's viewpoint.
    Diabetes technology & therapeutics, 2000,Spring, Volume: 2, Issue:1

    Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Insulin; Piperidines

2000